The Fly has brought its right-to-the-point stock market reporting to YouTube! Subscribe if you want to know how the markets will open and what stocks traders will be focused on.
Don’t Miss TipRanks’ Half-Year Sale
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on SRPT:
- Sarepta downgraded to Sell from Neutral at H.C. Wainwright
- Sarepta Therapeutics Maintains Buy Rating Amid Proactive Safety Measures for Elevidys Treatment
- Sarepta downgraded to Neutral from Overweight at Piper Sandler
- Sarepta Therapeutics: Buy Rating Affirmed Amid Strategic Safety Measures and Long-Term Potential
- Sarepta Therapeutics: Hold Rating Amid Elevidys Safety Concerns and Revised Sales Forecast